Oncogenic activation of Nrf2 by specific knockout of Nrf1α that acts as a dominant tumor repressor

Lu Qiu,Meng Wang,Shaofan Hu,Xufang Ru,Yonggang Ren,Siwang Yu,Yiguo Zhang
DOI: https://doi.org/10.1101/403220
2018-01-01
Cancers
Abstract:Liver-specific knockout of Nrf1 in mice leads to non-alcoholic steatohepatitis with dyslipidemia, and its deterioration results in spontaneous hepatoma, but the underlying mechanism remains elusive. A similar pathological model is herein reconstructed by using human Nrf1α-specific knockout cell lines. We demonstrated that a marked increase of the inflammation marker COX2 in Nrf1α−/− cells. Loss of Nrf1α leads to hyperactivation of Nrf2, which results from substantial decreases in both Keap1 and PTEN in Nrf1α−/− cells. Further investigation of xenograft mice showed that malignant growth of Nrf1α−/− -derived tumor is almost abolished by silencing Nrf2, while Nrf1α+/+ -tumor is markedly repressed by inactive Nrf2−/−ΔTA , but unaffected by a priori constitutive activator of caNrf2ΔN . Mechanistic studies unraveled there exist opposing and unifying inter-regulatory cross-talks between Nrf1 and Nrf2. Collectively, Nrf1α manifests a dominant tumor-suppressive effect by confining Nrf2 oncogenicity, while Nrf2 can directly activate the transcriptional expression of Nrf1 to form a negative feedback loop. HIGHLIGHTS
What problem does this paper attempt to address?